Atheromatous renovascular disease: Overview and challenges

Journal of Renal Care

Volumn 34, Issue 4, 2008, Pages 179-190

  Chrysochou, Constantina ^a   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Angioplasty and stent for renal arterial lesions (ASTRAL); Angiotensin converting enzyme inhibitors (ACE I); Angiotensin receptor blockers (ARB); Atheromatous renovascular disease; Atherosclerosis; CKDHypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANGIOPLASTY; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; DIAGNOSTIC IMAGING; HUMAN; KIDNEY ARTERY STENOSIS; METHODOLOGY; RENOVASCULAR HYPERTENSION; REVIEW;

ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; HUMANS; HYPERTENSION, RENAL; RENAL ARTERY OBSTRUCTION; RENAL INSUFFICIENCY, CHRONIC;

EID: 60749120690     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2008.00043.x     Document Type: Article

References (79)

1. Ansell D., Feest T., Feehally J. et al. (eds) (2007). UK Renal Registry, Treatment of adults and children with renal failure: standards and audit measures. 3rd edn. London: RCP London and the Renal Ass, 2002. Tenth Annual Report. Renal Association 2007.
2. Bakker J., Olree M., Kaatee R. et al. (1999). Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging Radiology 211, 623-628
3. Bart B.A., Gattis W.A., Diem S.J. et al. (1997). Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. American Journal of Cardiology 79, 1118-1120
4. Bloch M.J., Trost D.W., Pickering T.G. et al. (1999). Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. American Journal of Hypertension 12, 1-7.
5. Bonelli F.S., McKusick M.A., Textor S.C. et al. (1995). Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clinic Proceedings 70, 1041-1052
6. Burke T.A., Sturkenboom M.C., Lu S.E. et al. (2006). Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. Journal of Hypertension 24, 1193-1200
7. Cambria R.P., Brewster D.C., L'Italien G.J. et al. (1996). Renal artery reconstruction for the preservation of renal function. Journal of Vascular Surgery 24, 371-380
8. Caps M.T., Zierler R.E., Polissar N.L. et al. (1998). Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney International 53, 735-742
9. Casas J.P., Chua W., Loukogeorgakis S. et al. (2005). Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on rena outcomes: systematic review and meta-analysis. Lancet 366, 2026-2033
10. Chade A.R., Zhu X., Mushin O.P. et al. (2006). Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia FASEB Journal 20, 1706-1708
11. Cheung C.M., Patel A., Shaheen N. et al. (2007). The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clinical Practice 107, c35-c42
12. Cheung C.M., Shurrab A.E., Buckley D.L. et al. (2006). MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney International 69, 715-722
13. Cheung C.M., Wright J.R., Shurrab A.E. et al. (2002). Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. Journal of American Society Nephrology 13, 149-157
14. Chobanian A.V., Bakris G.L., Black H.R. et al. (2003). The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560-2572
15. Chrysochou C, Sinha S., Chalmers N. et al. (2007). Anuric acute renal failure and pulmonary oedema: a case for urgent action International Journal of Cardiology
16. Commission on Human Medicines. (2007a). Nephrogenic systemic fibrosis (NSF) with gadolinium-containing magnetic resonance imaging (MRI) contrast agents: update. Medicines and Healthcare Products Regulatory Agency Web site. http://www.mhra.gov.uk?home?idcplg?IdcService= SS-GET-PA&useSecondary = true&ssDocName =CON2031543&ssTargetNodeId = 221. Published June 26, 2007. Updated July19, 2007. Accessed Dec 23, 2007
17. Conlon P.J., Athirakul K., Kovalik E. et al. (1998). Survival in renal vascular disease. Journal of American Society Nephrology 9, 252-256
18. Conlon P.J., O'Riordan E. & Kalra P.A. (2000). New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. American Journal Kidney Disease 35, 573-587
19. Coulam C.H., Bouley D.M. & Sommer F.G. (2002). Measurement of renal volumes with contrast-enhanced MRI. Journal of Magnetic Resonance Imaging 15, 174-179
20. Dean R.H., Tribble R.W., Hansen K.J. et al. (1991). Evolution of renal insufficiency in ischemic nephropathy. Annals of Surgery 213, 446-455
21. Edwards M.S., Craven TE., Burke G.L. et al. (2005). Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Archives of Internal Medicine 165, 207-213
22. Farmer C.K., Cook G.J., Blake G.M. et al. (1999). Individual kidney function in atherosclerotic nephropathy is not related to the presence of rena artery stenosis. Nephrology, Dialysis, Transplantation 14, 2880-2884
23. Farmer C.K., Reidy J., Kalra P.A. et al. (1998). Individual kidney function before and after renal angioplasty. Lancet 352, 288-289
24. Garovic V.D. & Textor S.C. (2005). Renovascular hypertension and ischemic nephropathy. Circulation 112, 1362-1374
25. Goldsmith D.J., Reidy J. & Scoble J. (2000). Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy. American Journal of Kidney Disease 36, 837-843
26. Granillo G.A., van Dijk L.C., McFadden E.P. et al. (2005). Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovascular Intervention 64, 23-27.
27. Grobner T. (2006). Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrology Dialysis Transplant 21, 1104-1108
28. Guo H., Kalra P.A., Gilbertson D.T. et al. (2007). Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 115, 50-58
29. Harden P.N., MacLeod M.J., Rodger R.S. et al. (1997). Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 349, 1133-1136
30. Hillis G.S., Trent R.J., Winton P et al. (1996). Angiotensin-converting- enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence? Quarterly Journal of Medicine 89, 145-150
31. Holden A. & Hill A. (2003). Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. Journal of Vascular Surgery 38, 962-968
32. Iannone L.A., Underwood P.L., Nath A. et al. (1996). Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Catheterization and Cardiovascular Diagnosis 37, 243-250
33. Jackson B., Franze L, Sumithran E. et al. (1990). Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. Journal of Laboratory and Clinical Medicine 115, 21-27
34. Kakinuma Y, Kawamura T., Bills T. et al. (1992). Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic rena failure. Kidney International 42, 46-55
35. Kalra P.A., Guo H., Kausz A.T. et al. (2005). Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney International 68, 293-301
36. MacDowall P., Kalra P.A., O'Donoghue D.J. et al. (1998). Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 352, 13-16
37. Mailloux L.U., Napolitano B., Bellucci A.G. et al. (1994). Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. American Journal of Kidney Disease 24, 622-629
38. Makanjuola A.D., Suresh M., Laboi P. et al. (1999). Proteinuria in atherosclerotic renovascular disease. Quarterly Journal of Medicine 92, 515-518
39. Marckmann P., Skov L., Rossen K. et al. (2007). Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrology Dialysis Transplantation 22, 3174-3178
40. Messina L.M., Zelenock G.B., Yao K.A. et al. (1992). Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. Journal of Vascular Surgery 15, 73-80
41. Middleton J.P. (1998). Ischemic disease of the kidney: how and why to consider revascularization. Journal of Nephrology 11, 123-136
42. Missouris C.G., Buckenham T., Cappuccio F.P. et al. (1994). Renal artery stenosis: a common and important problem in patients with periphera vascular disease. American Journal of Medicine 96, 10-14
43. Mistry S., Ives N., Harding J. et al. (2007). Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far Journal of Human Hypertension 21, 511-515
44. Mounier-Vehier C, Cocheteux B., Haulon S. et al. (2004). Changes in renal blood flow reserve after angioplasty of renal artery stenosis in hypertensive patients. Kidney International 65, 245-250
45. Nordmann A.J., Woo K., Parkes R. et al. (2003). Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. American Journal of Medicine 114, 44-50
46. Peterson J.C, Adler S., Burkart J.M. et al. (1995). Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Annals of Internal Medicine 123, 754-762
47. Pickering T.G., Herman L., Devereux R.B. et al. (1988). Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet 2, 551-552
48. Plouin P.F., Chatellier G., Darne B. et al. (1998). Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 31, 823-829
49. Preston R.A. & Epstein M. (1997). Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. Journal of Hypertension 15, 1365-1377
50. Radermacher J., Chavan A., Bleck J. et al. (2001). Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. New England journal of Medicine 344, 410-417
51. Ratnam L.A., Nelson S.R. & Belli A.M. (2007). Investigating progressive unexplained renal impairment and hypertension. British Medical Journal 335, 1094-1096
52. Rimmer J.M. & Gennari F.J. (1993). Atherosclerotic renovascular disease and progressive renal failure. Annals of Internal Medicine 118, 712-719
53. Rodriguez-Lopez J.A., Werner A., Ray L.I. et al. (1999). Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. Journal of Vascular Surgery 29, 617-624
54. Schoenberg S.O., Knopp M.V., Londy F. et al. (2002). Morphologic and functional magnetic resonance imaging of renal artery stenosis: a multi-reader tricenter study. Journal of American Society of Nephrology 13, 158-169.
55. Schoolwerth A.C., Sica D.A., Ballermann B.J. et al. (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104, 1985-1991
56. Scoble J.E. (1999). Atherosclerotic nephropathy. Kidney International Supplement 71, S106-S109
57. Shekelle P.G., Rich M.W., Morton S.C. et al. (2003). Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. Journal of American College of Cardiology 41, 1529-1538
58. Shurrab A.E., MacDowall P., Wright J. et al. (2003). The importance of associated extra-renal vascular disease on the outcome of patients with atherosclerotic renovascular disease. Nephron Clinical Practice 93, C51-C57
59. Stanley J.C. (1997). David M. Hume memorial lecture. Surgical treatment of renovascular hypertension. American Journal of Surgery 174, 102-110.
60. Steinbach F., Novick A.C., Campbell S. et al. (1997). Long-term survival after surgical revascularization for atherosclerotic renal artery disease Journal of Urology 158, 38-41
61. Suresh M., Laboi P., Mamtora H. et al. (2000). Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrology Dialysis Transplantation 15, 631-636
62. Taal MW T.C. (2007). Renal Association Clinical Practice Guidelines for the Treatment of Patients with Chronic Kidney Disease
63. Tan J., Filobbos R., Raghunathan G. et al. (2007). Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrology Dialysis Transplantation
64. Textor S.C. (1998). Revascularization in atherosclerotic renal artery disease. Kidney International 53, 799-811
65. Tuttle K.R. (2002). Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosis. American Journal Kidney Disease 39, 1321-1322
66. van Ampting J.M., Penne E.L., Beek F.J. et al. (2003). Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrology Dialysis Transplantation 18, 1147-1151
67. van den Dool S.W., Wasser M.N., de Fijter J.W. et al. (2005). Functional renal volume: quantitative analysis at gadolinium-enhanced MR angiog-raphy-feasibility study in healthy potential kidney donors. Radiology 236, 189-195
68. van Helvoort-Postulart D., Dirksen C.D., Kroon A.A. et al. (2006). Cost analysis of procedures related to the management of renal artery stenosis from various perspectives. European Radiology 16, 154-160
69. van Jaarsveld B.C., Krijnen P., Pieterman H. et al. (2000). The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis Dutch Renal Artery Stenosis Intervention Cooperative Study Group. New England Journal of Medicine 342, 1007-1014
70. Van D.H., Rorive G. & Limet R. (1996). Reversal of acute renal failure by kidney revascularisation. European Journal of Vascular Endovascular Surgery 11, 134-139
71. van d, V, Beutler J.J., Kaatee R. et al. (1998). Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney International 53, 986-993
72. van d., V, Kaatee R., Beutler JJ. et al. (1999). Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 353, 282-286
73. Vasbinder G.B., Nelemans P.J., Kessels A.G. et al. (2001). Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Annals of International Medicine 135, 401-411
74. Webster J., Marshall F., Abdalla M. et al. (1998). Randomised comparison of percutaneous angioplasty vs continued medical therapy for hyperten-sive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. Journal of Human Hypertension 12, 329-335
75. Wright J.R., Duggal A., Thomas R. et al. (2001). Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for rena functional outcome in atherosclerotic renovascular disease. Nephrology Dialysis Transplantation 16, 765-770
76. Wright J.R., Shurrab A.E., Cheung C. et al. (2002). A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. American Journal of Kidney Disease 39, 1153-1161
77. Zambetis-Bellesis M., Dusting G.J., Mendelsohn F.A. et al. (1991). Autoradiographic localization of angiotensin-converting enzyme and angiotensin II binding sites in early atheroma-like lesions in rabbit arteries. Clinical and Experimental Pharmacology & Physiology 18, 337-340
78. Zeller T, Frank U., Muller C. et al. (2003). Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 108, 2244-2249
79. Zierler R.E., Bergelin R.O., Davidson R.C. et al. (1996). A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. American Journal of Hypertension 9, 1055-1061